Table 3.
Univariate analysis of prognostic parameters
OS | DFS | |
---|---|---|
|
|
|
Parameter | P value | P value |
Sex | ||
(Male/female) | 0.561 | 0.503 |
Age | ||
(≥ 45 vs. < 45) | 0.109 | 0.167 |
T stage | ||
(pI-II vs. pIII-IV) | 0.221 | 0.084 |
lymph node status | ||
(Y/N) | 0.740 | 0.602 |
Distant metastasis | ||
(Y/N) | 0.029 | 0.009 |
TROP2 overexpression | ||
(Y/N) | 0.026 | 0.021 |
Ki-67 overexpression | ||
(Y/N) | 0.019 | 0.012 |
EBER expression | ||
(Y/N) | 0.025 | 0.057 |
DFS-disease-free survival, OS-overall survival.